Author

Amer Mahmood

King Saud UniversityORCID 0000-0002-9199-0120Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:human· 3 Approach:statistical model· 3 Research Focus:differential expression· 2 Assay:whole-exome sequencing· 2 Research Focus:benchmarking· 1 Assay:bulk RNA-seq· 1 Assay:DNA methylation· 1 Assay:metabolomics· 1

Frequent Co-Authors

Masood A. ShammasiD· 3 shared Sarah AlMukhaylidiD· 3 shared Zafar IqbaliD· 3 shared Abdulaziz Siyal· 2 shared Nawaf AlanaziiD· 2 shared Aamer AleemiD· 1 shared Aamir Aleem· 1 shared Abdulkareem Al-GarniiD· 1 shared

Activity by Year

2023-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 33 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

3 shared papersGenetic & Genomic Medicine

Masood A. ShammasORCID

Mutual co-authors in cluster

Author profile →

3 papers

Recent·Most cited

Multi-Omics and AI-/ML-Driven Integration of Nutrition and Metabolism in Cancer: A Systematic Review, Meta-Analysis, and Translational Algorithm

Zafar Iqbal, Lubna Alnuaim, Abdulkareem Al-Garni, Nawaf Alanzazi, Sarah AlMukhaylid, Sultan Al Qahtani, Masood A. Shammas, Rizwan C. Naeem, Yaqob Samir Taleb, Tariq Karrar, Aamir Aleem, Amer Mahmood, Giuseppe Nicola Saglio

This paper reviews and analyzes how multi-omics and AI/ML approaches integrate nutrition and metabolism in cancer, showing strong diagnostic and predictive capabilities and proposing a clinical algorithm for low-resource settings.

medRxiv · Jul 29, 2025 · PreprintGenetic & Genomic Medicine

A retrospective case-control study for Clinical Validation of mutated ZNF208 as a novel biomarker of fatal blast crisis in Chronic Myeloid Leukemia

Nawaf Alanazi, Abdulaziz Siyal, SALMAN ABDUL BASIT, Masood A. Shammas, Aamer Aleem, Amer Mahmood, Sarah AlMukhaylid, Zafar Iqbal

This study validates ZNF208 mutation (c.64G>A) as a specific biomarker for advanced phase CML through targeted resequencing in a case-control cohort.

medRxiv · Mar 9, 2024 · PreprintGenetic & Genomic Medicine

Utilization of targeted resequencing for clinical validation of mutated FANCD2 gene as a promising molecular biomarker of early disease progression in Chronic Myeloid Leukemia

Nawaf Alanazi, Abdulaziz Siyal, Muhammad M. Absar, Masood A. Shammas, Sarah AlMukhaylid, Amer Mahmood, Zafar Iqbal

This study identifies a FANCD2 mutation as a specific biomarker for early progression in Chronic Myeloid Leukemia using targeted resequencing and NGS analysis.

medRxiv · Dec 19, 2023 · PreprintGenetic & Genomic Medicine